A pioneer in handheld fundus camera technology with integration to AI. MedTech from Finland, Enabling Screening for All. Optomed is a Finnish medical technology company and a leading provider of handheld fundus cameras. Our AI-powered screening solutions aim to transform diagnostic processes of various diseases, empower early detection, and improve people’s health through innovations. Two decades of pioneering expertise, we design cutting-edge retinal imaging technology that is trusted by healthcare professionals worldwide. Our technology is extensively patented, clinically validated and has approvals in all key markets, including CE, FDA and CFDA. Our products are sold via various sales channels in …

210 similar entities Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

Relentless medicine discovery. Tangram Therapeutics (formerly e-therapeutics) is a biotech company committed to uniting computation, RNAi, and unconventional thinking to make better medicines faster.

65 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Predicting life-changing drugs for patients with cancer Calico Biosystems is on a mission to help pharma companies create effective, affordable drugs faster to counter cancer multi-omics assay, computational modeling, drug efficacy prediction, combination therapy, and Cell and virus-based therapeutics' efficacy

344 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Pioneering a new era in precision medicine for women's health A clinical-stage biotechnology company pioneering a female-focused precision medicine approach using validated biobanks for the discovery, development, and commercialization of novel therapeutics and companion diagnostics in women's health. ovarian cancer, endometrial cancer, fibrosis, endometriosis, post surgical adhesions, surgery, women's health, fitness, health, lifestyle, precision medicine, Artificial Intelligence, Machine Learning, Biobank, gynecology, reproductive medicine, infertility, cervical cancer, pcos, femtech, life sciences, and healthcare

301 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology A.I.

bluebird bio has rebranded as Genetix Biotherapeutics, returning to our foundational roots and renewing our commitment to delivering transformative genetic therapies for patients living with sickle cell disease, β-thalassemia, and cerebral adrenoleukodystrophy. Follow our new page at the link below! gene therapy, gene addition, sickle cell disease, beta-thalassemia, and cerebral adrenoleukodystrophy

102 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

PulseSight is an ophthalmology drug development company developing disruptive non-viral gene therapies with minimally-invasive delivery technology to treat major eye diseases. Our mission is to develop life-changing solutions for patients with diseases leading to sight loss.

85 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Distribution of medical devices including superpulsed therapy lasers and PEMF therapy instruments Superpulsed therapeutic lasers: Lumix 2 Series, Superpulsed + CW therapeutic lasers: Lumix 3 Series, Superpulsed + CW therapeutic lasers: Lumix 4 Series, Lumix Lasers, superpulsed lasers, therapeutic lasers, medical devices, and technology

87 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Modern cancer care for the next billion people Hedera Dx enables health systems, patients and drug development programs to easily adopt advanced molecular testing and real-world evidence (RWE) capabilities. Join us on hederadx.com to learn more! Oncology, Next-Generation Sequencing, Liquid Biopsy, ctDNA, IVDR Compliance, Medical Device, Precision Medicine, and RWE

164 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

#BeyondInnovation #DermalFiller #CYTOSIAL #AestheticMedicine New ideas, new innovations, new ways of thinking for the medical device industry. We are a pharmaceutical company specialized in the discovery, clinical development, production and commercialization of innovative products in the field of regenerative medicine. At Bioxis Pharmaceuticals, we contribute to transform science into groundbreaking medical device that meet doctors need to improve the health and well-being of their patients in the field of dermatology and aesthetic medicine. Medical Device, Dermatology, Aesthetic, Cosmetic surgery, Regenerative medicine, Ultra-pure chitosan, and Hyaluronic Acid

202 similar entities Type: Startup Activities: healthtech manufacturing deeptech biotech Technologies: Synthetic Biology

Unlocking access to genes with unparalleled accuracy Our mission is to enable synthetic biologists, by using our technology to unlock access to genes with unparalleled accuracy. We produce genes for a range of biotechnology customers including those in the pharmaceutical, agriculture and diagnostics sectors. Our technology offers access to long and complex gene sequences, which are normally difficult to produce. We are based in Cambridge UK, but we serve companies across the world. Camena's technology is positioned to enable researchers and the synthetic biology revolution. Twitter: @camenabio DNA synthesis, Complex genes, Synthetic Biology, synbio, and Gene synthesis

122 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Creating value in eye health for our patients worldwide VISUfarma is a pan-European ophthalmic pharmaceutical company with a clear mission: to bring quality products and global therapeutic innovation to European eye health. We are an ambitious and fast growing ophthalmology company, commercializing a broad portfolio of pharmaceutical products and medical devices across Europe. (www.VISUfarma.com). The company was formed in 2016 and is the result of the successful combination of the Italian company Visufarma SpA and the commercial activities of the international Nicox SA, headquartered in France. The combination created VISUfarma. We offer a complete portfolio of products in the areas …

84 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

less complexity. more biology. At Chromodynamics, we are on a mission to deliver instruments that eliminate guesswork from drug development and prescription. Our unique technology allows for an enormous improvement in speed, efficacy, and cost with which exciting new treatments like immunotherapy are developed. We have been recognised as one of the most promising startups in the Eindhoven Brainport region and are expanding our team to ramp up our product development. Imaging systems, Multispectral imaging, Real-time analysis, Chemical imaging, Spectroscopy, Scientific instruments, Contract research, and Data analysis

931 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

CytoTronics no longer sells or supports the Pixel System and associated plates and software. The intellectual property of CytoTronics has been acquired by Axion BioSytems. Visit Axionbio.com to see what’s new! Electrophysiology, CMOS, Phenotypic Screening, Electrochemistry, Cell measurement, and Cell manipulation

69 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Biotech Company 100% Focused on Pediatric Cancer Drug Development A life science company exclusively focused on finding cures for childhood cancer by identifying and developing the most promising projects to create new treatments and drugs. drug development, clinical development, and childhood cancer

170 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

See beyond your cells. Advanced imaging solutions for research excellence. Logos Biosystems is the life science solutions of Aligned Genetics, Inc., dedicated to the development and commercialization of innovative technologies to support the life science research community. Since its founding in 2008, Logos Biosystems has been developing a series of automated systems and imaging instruments for laboratories engaging in research with a cellular and molecular emphasis.

60 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Disrupting retinal screening for medical purpose to improve people's quality of life D-EYE is changing medical care around the world by allowing healthcare professionals to quickly screen for problems, photograph and distribute them digitally via various secure wireless solutions. Our launch product is the low-cost, revolutionary Smartphone-Based Retinal Imaging System to promote earlier diagnosis of treatable eye conditions. This mobile health device is a combination of lenses and filters and a mobile app that turns a smartphone into a digital direct ophthalmoscope capable of recording high-definition video and still images of the posterior of the eye as well as transmitting …

92 similar entities Tags: H2020 Type: Startup Activities: healthtech biotech deeptech Technologies: Wireless

Targeted imaging and therapies Zionexa is an international and innovative company developing and commercializing molecular imaging solutions, in-vivo biomarkers for targeted therapies in oncology, to improve patients’ pathway and bring them a better quality of life. Molecular Imaging, Oncology, Targeted therapies, CDx, Radiopharmaceuticals, and Biomarkers

73 similar entities Type: Startup Activities: biotech deeptech

Dermo-innovation Feeligreen is a technology startup developing safe and effective micro-current devices for a wide range of cosmetic and therapeutic applications. With applications ranging from anti-ageing to wound healing, it develops and sells innovative drug-delivery systems to TIer1 pharmaceutical laboratories medical devices, therapeutics, cosmetics, and skincare

423 similar entities Type: Startup Activities: healthtech manufacturing deeptech biotech Technologies: Synthetic Biology

#Pharmaco-imaging, #nuclear medicine, #PET/MRI, #Radiochemistry, #Preclinical models Created in 2008 in Dijon, Pharm’image is a regional center of excellence in Pharmaco-imaging. Unique in France, it brings together hospitals, biotechnology, and pharmaceutical companies, to offer state-of-the-art of functional and molecular imaging technologies (MRI, PET, SPECT, CT), ranging from small-animal scale for preclinical experimentation to clinical exploitation Its aim is to deploy cutting-edge medical imaging technologies to evaluate biomarkers that can be used to track treatment efficacy and select the active and most promising drug candidates. imaging, preclinical evaluation, pharmacology, molecular imaging, nuclear medicine, radiochemistry, bioconjugation, translational research, in vivo pharmaco-imaging, First …

77 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

The Newcells ophthalmology business was acquired by Axol Bioscience Axol Bioscience Ltd. acquires ophthalmology business from Newcells Biotech Newcells Biotech is pleased to announce the acquisition of our ophthalmology business by Axol Bioscience Ltd., a leading drug discovery partner specialising in the development of in vitro models and specialist services. Learn more: https://axolbio.com/retinal-organoid-ophthalmology/ Induced pluripotent stem cells (iPSCs), Cellular reprogramming and differentiation, Supply of iPSC derived cells for drug development, Sourcing samples for human disease cell lines, Drug Transport Studies, RPE, Retinal Epithelia, Stem Cell Models, Disease Modelling, Retinal Epithelial Model, Toxicity, and Retina

104 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

A Revolutionary Platform for Regenerative Medicine Our jellyfish collagen-based innovation addresses complex regenerative medical needs, shaping next generation treatments and supporting current and future scientific research. At the heart of our products is marine-sourced Collagen Type 0, an evolutionary ancient stem collagen that is foundational, allowing greater applications across multiple indications. Medical Grade Collagen, Native Collagen, Cell Culture Reagents, Wound Healing, Hydrogels, Non Mammalian Collagen, Collagen, Reagents, Marine Biotechnology, regenerative medicine, 3dscaffolds, collagencoatedplates, and 3dsponges

75 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

New treatments for central nervous system disorders Neurolixis Inc. is a biopharmaceutical company focused on the discovery and development of novel drugs for the treatment of human central nervous system diseases including movement disorders, autism spectrum disorders, depression and pain. Neuroscience, Drug development, Parkinson's disease, Biased agonism, Orphan Drug, Autism, and Serotonin

179 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Late clinical stage company focused on drug discovery and development for the treatments of rare disorders of the CNS For additional information: info@sombiotech.com Pre-clinical validation, Licensing, In silico screening, Rare Diseases, Drug repurposing, Orphan CNS indications, Central Nervous System, Intellectual Property, and Artificial Intelligence

288 similar entities Type: Startup Activities: biotech deeptech legaltech Technologies: A.I. Synthetic Biology

Creating a new path for neurodegenerative diseases Tetraneuron is a drug discovery company, focused on the development of a disruptive gene therapy for Alzheimer’s Disease (AD) and an Early Biomarker for this neurodegenerative condition. alzheimer, terapia genica, gene therapy , disruptive therapy, Alzheimer´s Disease, Biomarker, neurodegenerative disease, neuroscience, neurociencia, enfermedades neurodegenerativas, neurodegeneration, dementia, and pioneering

138 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Giving back vision to blind people Phosphoenix is developing a prosthesis to stimulate nerve cells in parts of the brain that are involved in visual perception. The prosthesis uses electrodes placed in the brain via a proprietary probe to artificially stimulate nerve cells. Stimulating one electrode produces the perception of a dot of light and stimulating multiple electrodes can generate recognizable patterns. In the final product, the patient will wear a pair of glasses with an incorporated camera, enabling them to see a simplified image of the outside world via the electrical stimulation of patterns in the brain.

58 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

We are on a global mission to establish gene therapy as a new standard of care for the leading causes of vision loss. Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prevent blindness. Leveraging the research capabilities of its proprietary, intravitreal (IVT) platform, Adverum is developing durable, single-administration therapies, designed to be delivered in physicians’ offices, to eliminate the need for frequent ocular injections to treat these diseases. Adverum is evaluating its …

75 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Standard BioTools delivers the leading proteomic and multi-omic solutions that enable researchers to discover unique biological insights not accessible by other technologies. Mass Cytometry, Tissue Imaging, NGS Library Prep, Genotyping, Gene Expression, Copy Number Variation, Real-Time PCR, and Single-Cell Genomics

264 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Oxford, UK company exploiting the regenerative properties of silk for large gap peripheral nerve repair Newrotex is an Oxford-based SME that has developed the first implantable medical device capable of repairing 10cm peripheral nerve gaps, using the incredible properties of spider silk Peripheral Nerve Injury, Silk, Medical Device, Regenerative Medicine, and Biotech

101 similar entities Type: Startup Activities: biotech healthtech Technologies: Synthetic Biology

Automated 3D organoid screening technology We integrate standard assays on chip (eg. CRISPR, T-cell, cytotoxicity) to accelerate drug discovery from target to validation, and advance preclinical predictivity

512 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

New view for cancer therapeutics Sirius NeoSight is an innovative technological breakthrough company which aims to become a key player in the detection of subclinical neo-cancers, relapses and therapeutic monitoring of patients, thus offering doctors a new perspective on the therapeutic effectiveness implemented. Sirius NeoSight uses breakthrough patented technology from a consortium of academic laboratories with expertise in the field.

64 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Designer and manufacturer of medical devices for functional and stereotactic neurosurgery for the treatment of epilepsy. DIXI medical design and manufactures medical devices for functional and stereotactic neurosurgery for the treatment of epilepsy. Epilepsy, SEEG, and Electrodes

62 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

AbLeads is a young biotech startup developing innovative solutions in Oncology, through the generation of novel, personalized therapeutic antibodies. Learn More on https://ableads.fr Biotechnology, Oncology, Immunotherapy, Therapeutic Antibodies, and Personalized Medicine

359 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Igyxos develop more effective/efficient infertility treatment for patients Igyxos is a biotechnology company based out of CENTRE INRAe VAL DE LOIRE SITE DE TOURS, NOUZILLY, France. Biotechnologie, Fertilité, and anticorps monoclonal

180 similar entities Type: SMB Activities: biotech healthtech Technologies: Synthetic Biology

Explore the Unseen BioAxial is now part of Telight. Please follow our news at Telight LinkedIn page https://linkedin.com/company/telight TELIGHT specializes in a field of instruments employing light optics, in particular, providing innovative types and solutions for light microscopy. Super Resolution Microscopy, Fluorescence Microscopy, Conical Diffraction Optical Components, Nanoscopy, Living Cell Imaging, Low phototoxicity, Standard Workflow, Multicolor Imaging, and Intuitive

87 similar entities Type: Startup Activities: nanotech deeptech Technologies: Synthetic Biology

We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. biotech, medtech, cell therapy, gene therapy, CAR-T, MSC, iPS, ATMP, Tissue Engineering, cell based therapies, biotherapies, RMAT, and Manufacturing

227 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Nano Drug Solutions Revolutionizing neuropathy treatment Development of innovative nanomedicines targeting neuropathies, with a particular focus on hereditary neuropathies such as Charcot-Marie-Tooth disease Biothechnology

150 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Coave therapeutics Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare Ocular and CNS (Central Nervous System) diseases. We are pushing the boundaries of gene therapy through application of our AAV-Ligand Conjugates platform (ALIGATER) that enables targeted delivery, enhanced gene transduction and tissue distribution to improve the effectiveness of advanced gene therapies for rare diseases. Our strategy is to advance a pipeline of novel therapies targeting rare ocular and CNS diseases where targeted gene therapy has the potential to be most effective, where there is a clear unmet need and where success …

97 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Next-Generation Precision Medicine Approaches PredictCan is the first individual-centric preclinical platform to reproduce human biological diversity in vitro, enabling a true population-level "trial-in-a-dish" approach to predict drug efficacy, identify toxicity, and understand interindividual variability before clinical trials begin. Precision Medicine, Clinical Trial in the Dish, Personalized Care, Patient-derived models, Early Diagnosis, Solid Tumors, Cancer, Drug Screening, Pharmaco-Ethnicity, Artificial Intelligence, and Preclinical models

206 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology A.I.

We're on a mission to cure blindness with our transformational platform of advanced therapies. Aurion Biotech, Inc. (Aurion Biotech) is a clinical stage biotech company, developing a transformational platform of advanced therapies to cure blindness. Our first candidate is for the treatment of corneal endothelial disease, and one of the first clinically validated cell therapies for corneal care. CAUTION: New Drug—Limited by Federal (or United States) law to investigational use.

73 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Part of Odyssey Therapeutics Rahko was acquired by Odyssey Therapeutics in 2021. Odyssey Therapeutics is a biotech company pioneering next gen immunomodulators and oncology medicine. Read more: https://odysseytx.com/news/

63 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Dedicated to develop the medicines of the future VeonGen Therapeutics (formerly known as ViGeneron) was founded in 2017 as a spin-off of the Ludwig-Maximilians-University (LMU) Munich. At VeonGen Therapeutics we are dedicated to develop innovative gene therapies based on our two unique and proprietary technology platforms. VeonGen Therapeutics will leverage its two technology platforms to address unmet medical needs with in-house gene therapy programs for selected retinal disorders. Together with partners we will exploit our VeonGen Therapeutics technologies for additional indications. Gene Therapy, Inherited Retinal Disorders, and AAV vector

62 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

3D cell shape + AI to bring the right therapies to the right patients sooner Sentinal4D is an AI-powered cancer drug discovery and development company, with close ties to the Institute of Cancer Research. Sentinal4D represents a collaboration of physics, biology and artificial intelligence to drive novel cancer therapy candidates with a high probability of clinical success. Artificial Intelligence, Computer Vision, Systems Biology, and Drug Discovery

64 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology

“Inspiring Minds Advancing Science” Life Sciences BC is a not-for-profit, non-government, industry association that supports and represents the life sciences community of British Columbia through leadership, facilitation of investment and partnering, advocacy, and promotion of our world-class science and industry. Biopharmaceuticals, Medical Devices, Medical Technologies, and Digital Health Care

278 similar entities Type: SMB Activities: healthtech biotech deeptech Technologies: Synthetic Biology

Pioneering treatments for Stargardt disease and Usher 1B, addressing the root cause of the disease AAVantgarde is a clinical stage, biotechnology company advancing best-in-class therapies for patients with inherited retinal diseases (IRDs). With a strong foundation in translational science and a commitment to clinical excellence, AAVantgarde is working to bring transformative therapies to patients. Gene Therapy, Ophthalmology, and Rare diseases

89 similar entities Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology

Follow us at Shionogi Inc. for news about our rare disease research programs https://www.linkedin.com/company/shionogi-inc-/ drug discovery, PDE4D, PDE4B, Fragile X, CTE, Rubinstein-Taybi, traumatic brain injury, Clinical Trials, Fragile X syndrome, Cognition, BPN14770, and Memory Loss

364 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

A Shimadzu group company Biomaneo specializes in the design and marketing of innovative medical analysis kits based on the fine analysis of proteins by mass spectrometry for neonatal screening and the diagnosis of various pathologies in hospital laboratories. Screening and Diagnosis, Mass Spectrometry, Medical Device, and Biological Markers

244 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Applying pathbreaking science to transform the lives of patients with severe retinal neurodegenerative diseases GenSight Biologics is a clinical-stage biotechnology company discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system. GenSight Biologics’ pipeline leverages two core technology platforms, the Mitochondrial Targeting Sequence (MTS) and optogenetics for retinitis pigmentosa, to help preserve or restore vision in patients suffering from severe degenerative retinal diseases. GenSight Biologics’ lead product candidate, GS010, is in Phase III trials in Leber’s Hereditary Optic Neuropathy (LHON), a rare mitochondrial disease that leads to irreversible low vision and legal blindness in …

59 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Gecko Biomedical is a fast-paced medical device company, dedicated to the development of innovative tissue reconstruction solutions. We are leveraging our technology platforms to develop novel solutions to disrupt the field of surgery and positively impact the life of patients.

153 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Synthetic Genetic Systems for next generation biomedicines and bioprocesses. SynGenSys creates product-specific libraries of synthetic genetic parts for next-generation biomedicines and biomanufacturing processes. Our philosophy is simple: all products and production processes are unique. Therefore core genetic assemblies used for therapy or biomanufacturing should harbour custom synthetic DNA parts and circuits designed to be fit for a specific purpose. Life Science, Biopharma, Cell Therapy, and Gene Therapy

82 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Our mission: find solutions for hearing disorders Sensorion is a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders Its clinical-stage portfolio includes one Phase 2 product: SENS-401 (Arazasetron) progressing in a planned Phase 2 proof of concept clinical study of SENS-401 in Cisplatin-Induced Ototoxicity (CIO) and, with partner Cochlear Limited, a study of SENS-401 in patients scheduled for cochlear implantation. Sensorion has entered into a broad strategic collaboration with the Institut Pasteur focused on the genetics of hearing. It has two gene therapy programs …

66 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

EryPharm is a biotech start-up company dedicated to the development and the operation of a large-scale process for the production of Red Blood Cells from stem cells. The technology has been developed by Dr. Luc Douay and his team at the Paris Sorbonne university. You can contact EryPharm through our website: http://erypharm.com/contact.html Or you can contact Loïc Tron directly: www.linkedin.com/in/loictron

61 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases neurodegeneration, RNA therapeutics, physiological upregulation, post-transcriptional upregulation, mRNA, ASO, and SINEUP

209 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Entreprise de dispositif médical de diagnostic in vitro : Noratest® In vitro diagnostic medical device Diagnostic, Innovation, Maladies neurodégénératives, Alzheimer, Neurosciences, Entreprise, and Entrepreneuriat

349 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Biotechnology company focused on in vitro preclinical research using cell imaging. By court decision dated May 16, 2024, the company SAS HCS Pharma was placed in liquidation and its business assets were transferred to the company SAS NETRI, following the order of the Commercial Court of Lille Metropole dated October 30, 2024. High Content Screening, in vitro pharmacology, HCA, in vitro toxicology, High Content Analysis, cellular imagery, eADME, bretagne, HCS, britany, 3D culture, and BIOMIMESYS

111 similar entities Type: Startup Activities: deeptech Technologies: 3D Printing Synthetic Biology

Accelerating drug discovery to transform patients' lives Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com Biopharmaceuticals, Orphan Disease Therapeutics, Rare Diseases, and Serious Diseases

519 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Transformation in Sight Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company based in Cambridge, Mass., dedicated to preserving the sight of individuals impacted by retinal diseases. Biopharmaceuticals, Rare Disease, Inherited Retinal Disorders, Genetic Diseases, Retina, and Ophthalmology

55 similar entities Type: Startup Activities: deeptech

Sylentis is an European biotechnological company founded in 2006. Sylentis focuses on researching new therapeutic approaches based on gene silencing. Our company is specialised in developing ophtalmologic therapies via interference RNA, a powerful tool for rational drug design. Most advanced product of the company are treatments for glaucoma and dry eye syndrome. Sylentis is a wholly owned member of PharmaMar (www.pharmamar.com) Gene Sinlencing, siRNA RNAi Drugs, Ophtalmology, Biotechnology, RNAi, R&D, Pharmaceuticals, Bioinformatics, Biotecología, Biotech, Experimental drugs, Glaucoma, Dry eye syndrome, Target Therapies, Production, eyes diseases, RNAi Clinical Trials, Ophthalmology, Licensing, Research, Drug Discovey, and Rational Design

86 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Curing blindness with regenerative cell therapies. StemSight develops off-the-shelf regenerative cell therapies for corneal blindness. Our expertise is in the combination of iPS-derived cells with functional biomaterials - for FASTER tissue regeneration, SAFER cell therapies and EASIER cell delivery.

64 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Transforming cancer and autoimmune treatments with unique IL-1RAP targeting approaches Advesya is a pioneering and transformative biotechnology company developing therapies for difficult-to-treat cancers. Haematology & Oncology, Antibody Drug Conjugate, Cell Therapy, and Autoimmune

565 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Dedicated to developing treatments for rare diseases originated from nonsense mutations Genvade aims to harness the power of nonsense mutation readthrough molecules to develop treatments for some of the most burdensome rare diseases. Our lead compound targets indications include cystic fibrosis, Duchenne muscular dystrophy and other genetic diseases. small molecules, drug discovery and development, rare diseases, nonsense mutation corrector, cystic fibrosis, genetic diseases, oncology, readthrough, and Duchenne

142 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Laboratoires Théa is a pharmaceutical industry specialized in ophthalmology. The group is the leader in several therapeutic classes as well as in the field of preservative-free eye drops. Laboratoires Théa is an innovative company dedicated to developing high-quality products that support ophthalmic care and eye health across more than 70 countries. Ophthalmology, Pharmaceuticals, Medical Devices, Eye care, Eye Health, and Preservative-free

83 similar entities Type: SMB Activities: healthtech biotech deeptech Technologies: Synthetic Biology

Smartox Biotechnology is specialized in peptide research and manufacturing Smartox Biotechnology is specialized in peptide research and engineering. Peptide synthesis, physiology, pharmacology, neuroscience, ion channel research, toxin, venomous animals, and screening library

297 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Smart active ingredients, safer sun exposure Catalonia Exponential Leader 2023 Roka Furadada’s mission is to reduce the incidence of skin cancer through research, development and production of active ingredients and medical devices, with high efficiency and low toxicologic and environmental impact OUR PURPOSE Roka Furadada wants to help to prevent and reduce the incidence of skin cancer. HOW ARE WE GOING TO DO IT? Developing the first intelligent ultra violet radiation filter: SMART UV, with new molecules that entail therapeutic activity to prevent and treat diseases associated with sun exposure. Cosmetics, Raw Materials , Ingredients, Cosmetic Ingredients, Sunscreen, Sun protection …

132 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Ocular Therapeutix, Inc. is a biopharmaceutical company committed to redefining the retina experience across drug development, treatment, and outcomes. AXPAXLITM (also known as OTX-TKI), an investigational axitinib hydrogel administered by intravitreal injection, is Ocular’s leading investigational candidate for retinal disease, based on its proprietary ELUTYXTM technology. AXPAXLI is currently in Phase 3 clinical trials for wet age-related macular degeneration (wet AMD) and has potential applications across other retinal diseases such as non-proliferative diabetic retinopathy (NPDR) and diabetic macular edema (DME). Retina, Retinal Disease, Wet AMD, NPDR, DME, Anti-VEGF, Tyrosine Kinase Inhibitors, Ocular Drug Delivery, Sustained Delivery, Ophthalmic Therapies, and Ophthalmology

69 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Driving collaboration in drug, device, and diagnostics development in pursuit of a healthier world DIA is the leading global life science membership association driving collaboration in drug, device, and diagnostics development in pursuit of a healthier world. Founded in 1964 with headquarters in Washington, D.C., and offices in Europe and Asia, DIA provides unparalleled networking opportunities, educational resources, scientific research publications, and professional development programs to members in more than 80 countries. Professional Association, Pharmaceuticals, Medical Devices, Biotechnology, Education Provider, Government, Clinical Trials, Education, Training, eLearning, Translational Medicine, Patient Engagement, Value and Access, healthcare, regulatory affairs, Pharmaco Vigilance, personaldevelopment, careers, …

78 similar entities Type: SMB Activities: healthtech edtech govtech deeptech biotech Technologies: Synthetic Biology

Enabling gentle live cell confocal microscopy and live cell imaging in Super resolution. At Confocal NL, our mission is to improve the microscopy experience of researchers. We help researchers accelerate their discoveries by offering them confocal imaging solutions that respect their specimens and minimize phototoxicity. confocal microscopy, super resolution microscopy, near infrared confocal, deep imaging, live cell imaging, and 3D imaging

60 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Reshaping rhBMP-2 Perspectives Relieving suffering and improving quality of life with next-generation orthobiologics. Regenerative Medicine, Biomaterials, Medical devices, Drug delivery, biotechnology, BMP2, Programmed Drug Release, and Instructive Tissue Scaffolds

230 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

A new hope for patients affected by Alzheimer’s disease CaSRevolution is a research company specialized in devising innovative therapies for neurodegeneration diseases We have discovered a new mechanism that explains the progression of Alzheimer’s Disease and identified a potential therapeutic approach biotech, neurodegeneration, startup, and alzheimer

129 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

VisusNano Ltd. is a privately held pre-clinical company developing a drug-eluting intraocular lens implant, for use in patients undergoing cataract surgery. By improving patient outcomes, obviating the need for eye drops after surgery, and avoiding the need for YAG laser capsulotomy after surgery, our device has the potential to revolutionise cataract surgery in both the human and veterinary markets.

65 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Delivery of vision care EyeD Pharma is a clinical stage pharmaceutical company dedicated to improving the life of patients suffering from ophthalmic diseases with unmet medical needs such as glaucoma or dry eye. We develop innovative therapeutic solutions based on sustained release polymeric micro-implants and inserts.

127 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Visionary science for life-changing cures. AGTC is a clinical-stage biotechnology company that uses its proprietary gene therapy platform to develop products designed to transform the lives of patients with severe diseases, with an initial focus in ophthalmology. AGTC's lead product candidates are designed to treat inherited orphan diseases of the eye, caused by mutations in single genes that significantly affect visual function and currently lack effective medical treatments. AGTC's product pipeline includes six named ophthalmology development programs across five targets (X-linked retinoschisis (XLRS), X-linked retinitis pigmentosa (XLRP), achromatopsia, wet age-related macular degeneration and blue cone monochromacy), two non-ophthalmology programs (alpha-1 …

59 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Reversing Neurodegeneration - Restoring Life GeneCode is developing small-molecule drugs that bind and activate GDNF (Glial cell line-Derived Neurotrophic Factor) receptors for the treatment of Parkinson’s disease (PD) and other neurodegenerative conditions.

119 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Bringing precision to the power of biologics with pioneering use of synthetic nanoclays for regenerative medicine. Renovos Biologics Ltd. (Renovos) is a biotech/medtech company focussed on the development of its patented synthetic nanoclay, RENOVITE®, as a drug delivery platform for regenerative medicine and beyond. Regenerative Medicine, Biomaterials, Drug Delivery, Medical Devices, Pharmaceuticals, Stem Cells, Orthopaedics, and Biotechnology

109 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We believe that everyone - irrespective of who they are or where they live - deserve medications that work We believe that everyone - irrespective of who they are or where they live - deserve medications that work

310 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Selvita is one of the largest preclinical contract research organizations in Europe, driven by a clear mission: to offer a comprehensive scope of services bridging the gap between early drug discovery and the clinical stage of drug development. biotechnology, pharmaceuticals, drug discovery, preclinical research, bioanalytical development services, bioinformatics, systems biology, proteins, genomics, proteomics, autoimmune disorders, regulatory studies, medicinal chemistry, agrochemical, industrial chemistry, and assay development&screening

514 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Revolutionizing drug delivery HHC medical is a health tech startup developing a platform technology for targeted and non-invasive drug delivery via wireless electroporation. Drug Delivery, Genetic therapies, and Enabling life-altering therapies

296 similar entities Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology

Pioneering Therapies for Neuropathic Corneal Pain and Inflammation. NASDAQ: OKYO OKYO Pharma is a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an FDA approved therapy, and for inflammatory eye diseases.

70 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Light Activated Therapeutics Lightox has developed a new drug for the treatment of early stage oral cancers. The topically applied formulation allows for specific delivery to the lesion and is activated by a specific wavelength of light.

67 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Visionary Care Since 1935 always committed to improve patients’ quality of vision. SIFI is expanding into international market providing innovative solutions for ocular diseases. Eye Care, Pharmaceutical/Nutraceuticals/Medical Devices, Surgical & Diagnostic Medical Devices., Ophthalmology , Science, Researchers , Research, Vision, Eyes, Surgical, Medical technology, Health, Medicine , Eye health , and Biotech

90 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Neem’s Hill is a holding company focused on investments and innovations in the medical device sector. Through its portfolio companies, it develops and commercializes patented Tumour Specific Electroporation (TSE) technology for cancer treatment. Today, the Group operates in both Human Care and Animal Care, with the ambition to improve clinical outcomes while reducing side effects through innovative, tissue-preserving cancer treatments. Cancer Treatments, Research, Clinical Development, Chemotherapy, and Immunotherapy

307 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Contraline is a venture-backed, clinical-stage biotechnology company at the forefront of male contraception. medical device, biotechnology, urology, contraception, womenshealth, reproductivehealth, and menshealth

252 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

BioLogos explores God’s Word and God’s World to inspire authentic faith for today. BioLogos explores God’s Word and God’s World to inspire authentic faith for today. evolution, creationism, intelligent design, biblical scholarship, genetics, cell biology, christianity, jesus, theology, creation care, bioethics, christian ethics, and human identity

53 similar entities Type: Startup Activities: biotech Technologies: Synthetic Biology

Making Regenerative Medicine Accessible Roumai Medical is developing next-generation biotechnologies in regenerative medicine and human-machine interface to meet the unmet clinical needs of millions of patients worldwide.

207 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Better Technology. Better Delivery. Developing a new generation of disease-modifying therapies. Driven by our proprietary Enhanced Delivery Oligonucleotide (EDO) platform, we are creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic neuromuscular and neurological disorders. Biotechnology, Chemistry, Biology, Bioscience, Life sciences, and Therapeutics

296 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Transforming the lives of patients through gene therapy uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with severe genetic diseases. aav, Huntington's disease, gene therapy, ALS, epilepsy, and Fabry disease

257 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Building on innovative science to create treatments for patients in need ResoTher Pharma ApS is a biotechnology company focused on developing novel and effective peptide therapeutics for cardiovascular disease by targeting inflammation. Biotechnology, Drug Development, and Pharmaceutical Industry

535 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We’re using ground-breaking cell technologies to revolutionise global food production - starting with pork Uncommon Bio began with cell-based meat and pioneered RNA delivery innovations, which evolved into their most recent spin out which is focusing on changing medicine through multi-targeting. Their polysaccharide-based delivery platform enables multi-pathway cell programming, offering a safe, efficient and scalable alternative to multi-target therapies. The company is initially targeting severe lung diseases like idiopathic pulmonary fibrosis and is backed by industry leaders from BioNTech and top investors, including Sam Altman, Balderton, Lowercarbon, and Redalpine. science+art, biotech, mRNA, IPF, Pulmonary fibrosis, and delivery

561 similar entities Type: Startup Activities: biotech deeptech foodtech Technologies: Synthetic Biology

A clinical-stage biotech pioneering a portfolio of disease-transforming therapeutics for CNS-mediated conditions Noema Pharma is a biotech company developing groundbreaking therapies to address the most disabling symptoms in orphan conditions of the brain and nervous system. Noema’s research and development is focused on understanding and meeting patient needs using our novel therapies. CNS

74 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Ilya Pharma 🇸🇪🇺🇸 is bringing local-acting immunotherapies to patients Delivering local-acting immunotherapies to patients ATMP, Gene Therapy, Drug development, Clinical trials, GMP, IBD, Wound treatment, Scar, Topical, Oral, Research, Science, Immunology, Immunophysiology, microbiology, Applied microbiology, Regulatory excellence, Skin, Diabetes, IBD, Cysticfibrosis, SAVI, colitis, Cystic fibrosis, and Inhalation

646 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Reinventing Chemistry for Life Sciences The leading innovator and manufacturer of photoreactors, metabolites and LEDs since 2008 Metabolite synthesis, photochemistry, research instrument, and photoreactor

115 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

OPUS Life Sciences, LLC is dedicated to addressing the needs of healthcare providers and patients through innovative eye care supplements, eyelid wipes, eye vitamins and more. We’re constantly discovering and developing new medicines, devices and supplements for eye health to improve peoples’ quality of life.

65 similar entities Type: Startup Activities: biotech deeptech healthtech manufacturing

Advancing precision oncology therapeutics designed to deploy multi-faceted inhibition to reverse cancer resistance AUM Biosciences is focused on advancing a clinical pipeline of precision oncology therapeutics designed to deploy multi-faceted inhibition strategies to reverse cancer resistance biotech, oncology, drug development, Asian-biotech, Precision medicine, Digitalhealth, cancer, and small molecules

370 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Drugging disordered proteins with physics and AI Peptone is a therapeutics company that uses AI and an experimental physics product engine to design small molecules targeting the 6,200 intrinsically disordered human proteins that Alpha Fold 3 cannot model. artificial intelligence, structural biology, high performance computing, supercomputers, biotechnology, and intrinsically disordered proteins

109 similar entities Type: Startup Activities: biotech deeptech it services Technologies: Synthetic Biology

Rabbit genetic selection. Rabbit genetic selection & sale of breeding animals: durability, robustness, ease of management and breeding performance in the rabbit sector.

47 similar entities Type: SMB Activities: deeptech

business development mission in Life Sciences IVD Cosmetic finding new customers finding new partners BtoBioInnovation offers outsourced services in Marketing & Business Development in Life Sciences, Biotech, Molecular Diagnostics, Cosmetic, Nutraceutical : - Operational Marketing : representation on Trade shows, congresses, Seminar organisation - E-Marketing: E-mailing Campaign, Google Analytics, webinars - Strategic Business Development: Chinese Market, Trends in oncology, Neurology, Biomarkers, Molecular Diagnostics, coaching for Negociation & Due Diligence, Analysis of Pharma & Biomedical Industries. - Operational Business Development: Identify & qualify new customers, partners, distributors, Sourcing licensing opportunities, Marketing, Business development, Biotech, Life sciences, In vitro diagnostics, Cosmetic, Nutraceutical, …

222 similar entities Type: SMB Activities: martech biotech Technologies: Synthetic Biology

Transforming Energy into Therapy Galvanize Therapeutics is developing therapies to deliver life-changing healthcare solutions to patients and their doctors at the convergence of biology, engineering, and care delivery. medical device, COPD, AF, Oncology, Intervential Oncology, Intervential Pulmonology, AFib, PEF, PEF Ablation, Soft Tissue Ablation, Cardiac Arrhythmias, and Chronic Bronchitis

451 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Developing a new generation of therapies to protect, restore, and improve vision EyeBio is a privately held ophthalmology biotechnology company dedicated to developing and delivering a new generation of therapies to protect, restore, and improve vision in patients with sight-threatening eye diseases. ophthalmology, biopharmaceuticals, and biotechnology

63 similar entities Type: Startup Activities: biotech deeptech

Pioneering a new class of treatments for significant neuro-visual disorders. Luminopia is pioneering a new class of treatments for significant neuro-visual disorders. Luminopia is committed to creating digital therapeutics that are both rigorously evaluated for FDA approval and genuinely engaging for patients. As an Innovation Partner of Boston Children’s Hospital, the company is developing its lead product to treat amblyopia, the leading cause of vision loss among children. For more information, visit luminopia.com. Please see Luminopia Directions For Use for more information: luminopia.com/dfu digital health, healthtech, amblyopia, lazy eye, ophthalmology, and neuroscience

61 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Discovering from green - Scientific research aimed at obtaining plants with better productivity, fruit quality or with properties of high added value (of interest to the consumer, farmers and the agri-food industry) and more resistant to stress, as well as less dependent on chemical treatments, in order to contribute to less aggressive agriculture with the environment. - Advanced services in Genomics, Proteomics, Metabolomics, Bioinformatics, Microscopy, Plant Hormone Quantification, DNA Sequencing and Gene Expression Analysis. - Training of research personnel. Biotechnology, Molecular Biology, Genomics, Proteomics, Bioinformatics, Metabolomics, Systems Biology, and Synthetic Biology

182 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Transforming the lives of patients with degenerative diseases through a novel class of in vivo reprogramming therapies. Mogrify® has developed a proprietary suite of platform technologies that utilize a systematic big-data approach to direct cellular reprogramming (Rackham et al., Nature Genetics, 2016) and the maintenance of cell identity (Kamaraj et al., Cell Systems, 2020). The platforms, MOGRIFY® and epiMOGRIFY®, developed over a 12-year period via a multi-national research collaboration, deploy next-generation sequencing, gene regulatory and epigenetic network data to enable the prediction of the transcription factors and growth factors required to produce any target human cell type from any source …

60 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. A.I. - Machine Learning Synthetic Biology